Clinical Trial

A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement

Name: A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement — clinical trial record (NCT06985615)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated May 22, 2025 (before its estimated January 14, 2026 completion). Its status may not reflect the trial's current state.

Summary

The current study is proposed to evaluate whether there is any clinically meaningful effect of hepatic impairment on the plasma Pharmacokinetic (PK) of HDM1002

Trial Details

NCT Number	NCT06985615
Lead Sponsor	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Conditions	Hepatic Impairment, Healthy Volunteers
Enrollment	40 participants
Start Date	2025-03-18
Primary Completion	2026-01-14 (estimated)
Study Completion	2026-05-14 (estimated)
Updated on ClinicalTrials.gov	2025-05-22